JANX icon

Janux Therapeutics

49 hedge funds and large institutions have $388M invested in Janux Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$24.3M
2 +$5.71M
3 +$1.54M
4
Morgan Stanley
Morgan Stanley
New York
+$1.54M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.5M

Top Sellers

1 -$658K
2 -$609K
3 -$141K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$27K
5
Goldman Sachs
Goldman Sachs
New York
-$24.6K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$117M
2
$84.6M
3
$53.1M
4
$25.1M
5
$19.9M
6
$19.2M
7
$16.9M
8
$10.3M
9
$6.04M
10
$5.42M
11
$5.42M
12
$4.88M
13
$4.53M
14
$3.58M
15
$1.92M
16
$1.85M
17
$1.43M
18
$1.42M
19
$987K
20
$679K
21
$669K
22
$631K
23
$452K
24
$346K
25
$206K